MemoTril Brain Supplement Claims Examined in 2026 Report

Got story updates? Submit your updates here. ›

A 2026 consumer report examines the brain supplement MemoTril, including its listed ingredients, marketing claims, and what research supports the individual compounds. The report notes that while some MemoTril ingredients like Bacopa monnieri and phosphatidylserine have published studies, the specific dosages in the MemoTril formula are not disclosed, and no clinical trials have evaluated the finished product. The report advises consumers to verify ingredient transparency, refund policies, and consult healthcare providers before purchasing any cognitive support supplement.

Why it matters

As consumer interest in brain health supplements continues rising, this report provides an independent examination of MemoTril's marketing claims, ingredient research, and what consumers should consider before purchasing cognitive support products. The report highlights the differences between ingredient-level studies and product-level clinical evidence, emphasizing the need for transparency around supplement formulations.

The details

MemoTril is a dietary supplement marketed as a natural cognitive support formula containing six primary ingredients: Bacopa monnieri, Lion's Mane Mushroom, Ginkgo biloba, phosphatidylserine, Rhodiola rosea, and omega-3 DHA. While some of these individual compounds have published research behind them, the specific dosages used in the MemoTril formula are not disclosed on the publicly available product page. Without knowing the exact amounts of each ingredient, consumers cannot directly compare the MemoTril formulation to the dosages used in clinical studies of the isolated compounds. Additionally, no published clinical trials appear to have evaluated the finished MemoTril product itself.

• This 2026 consumer report was published on March 4, 2026.